patient selection in the treatment of nhl
Published 3 years ago • 34 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:27
the next steps in the treatment of nhl
-
4:23
the changing role of chemotherapy in the treatment of various subtypes of nhl
-
2:38
personalising treatment to the biology of the nhl patient
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
2:19
novel treatment options for non-hodgkin lymphoma
-
2:43
tim wassenaar, md, hematologist
-
2:54
non-hodgkin's lymphoma treatment expectations
-
1:51
checkpoint inhibition in the treatment of mpns
-
1:22
diagnostics and treatment outcomes from primary cbcl
-
1:32
using appropriate criteria when selecting patients with hl for radiation therapy
-
1:35
update on phase i study of plamotamab in r/r nhl
-
1:30
recent updates in hl research & the importance of improving treatment for elderly & frail patients
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:34
pet-guided treatment: the new standard of care in hodgkin lymphoma?
-
1:12
the use of end-of-treatment pet in early-stage hodgkin lymphoma
-
3:05
the benefits of pet in the prognosis and treatment of hl
-
1:51
refract: standard chemoimmunotherapy versus novel agents in r/r follicular lymphoma
-
1:58
outcomes of patients with hodgkin lymphoma undergoing allohsct after pembrolizumab therapy
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl